Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

    Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini
    e2017046
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.046
    2698
    PDF: 1008
    HTML: 1114
  • THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

    Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto
    e2025023
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.023
    1080
    PDF: 1157
    HTML: 98
  • TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

    PIMJAI NIPARUCK
    e2021063
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.063
    1179
    PDF: 532
    HTML: 211
  • Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

    Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo
    e2020040
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.040
    1075
    PDF: 688
    HTML: 201
  • Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

    Mauro Passucci, Giovanni Assanto, Alessandro Pulsoni
    e2023018
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.018
    1214
    PDF: 915
    HTML: 363
  • OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett
    e2018020
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.020
    2885
    PDF: 831
    HTML: 377
  • SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

    Massimo Breccia, Giuliana Alimena
    e2014003
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.003
    3274
    PDF: 1224
    HTML: 3474
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    4010
    PDF: 1056
    HTML: 3601
    Untitled: 178
    Cneo. Fig.1: 115
    Untitled: 106
    Untitled: 128
    Untitled: 135
  • The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

    Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso
    e2022041
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.041
    1273
    PDF: 769
    HTML: 319
  • CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates

    Luciana Teofili
    e2019021
    2019-02-25
    https://doi.org/10.4084/mjhid.2019.021
    1967
    PDF: 1145
    HTML: 252
  • Myeloid neoplasms with isolated isochromosome 17q: a yet to be defined entity

    Eleftheria Lamprianidou, Chryssoula Kordella, Menelaos Papoutselis, Zoi Bezyrgiannidou, Evangelia Nakou, Spyros Papamichos, Emmanouil Spanoudakis, Andreas Giannopoulos, Katerina Zoi, Ioannis Kotsianidis
    e2017066
    2017-11-01
    https://doi.org/10.4084/mjhid.2017.066
    2293
    PDF: 784
    HTML: 827
  • Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

    Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç
    e2026026
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.026
    489
    PDF: 350
    HTML: 170
  • Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines

    Alex Shimanovsky, Devbala Patel, Jeffrey Wasser
    e2016010
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.010
    4267
    PDF: 1191
    HTML: 2164
    Figure 1: 170
  • A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

    Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi
    e2024013
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.013
    931
    PDF: 1176
    HTML: 163
  • TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

    Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso
    e2017045
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.045
    4364
    PDF: 1767
    HTML: 1111
  • THE CHALLENGE OF AML IN OLDER PATIENTS

    Alan K Burnett
    e2013038
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.038
    2193
    PDF: 967
    HTML: 2171
  • HEALTH-RELATED QUALITY OF LIFE MEASUREMENT IN ADULTS WITH SICKLE CELL DISEASE IN STEADY STATE: EXPERIENCE OF ONE FRENCH REFERENCE CENTER

    Giovanna Cannas, Solene Poutrel, Emilie Virot, Manon Marie, Alexandre Guilhem, Amal El-Kanouni, Richard Bourgeay, Marie-Grace Mutumwa, Mohamed Elhamri, Arnaud Hot
    e2025065
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.065
    985
    PDF: 531
    Html: 147
  • Ixazomib-associated skin exfoliation

    Yali Zhang, Long Zhao, Yuancheng Guo, bei liu
    e2022045
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.045
    861
    PDF: 548
    HTML: 212
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1563
    PDF: 1034
    HTML: 233
  • DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

    Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
    e2023008
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.008
    1335
    PDF: 1230
    HTML: 457
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1581
    PDF: 639
    HTML: 6876
  • PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

    Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen
    e2023026
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.026
    4731
    HTML: 321
    PDF: 1249
  • LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

    kang sun
    e2024037
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.037
    2775
    PDF: 1092
    HTML: 121
251 - 273 of 273 items << < 1 2 3 4 5 6 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy